Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wang, Keqing ^a   Hampson, Peter ^a   Hazeldine, Jon ^a   Krystof, Vladimir ^b   Strnad, Miroslav ^b   Pechan, Paul ^c   Lord, Janet M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

^c C3Bio Ltd   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN T1; FLAVOPIRIDOL; ONCOPROTEIN; PROTEIN BCL 2A; PROTEIN MCL 1; PROTEIN P TEFB COMPLEX; UNCLASSIFIED DRUG; CDK5 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN-DEPENDENT KINASE-ACTIVATING KINASE; FLAVONOID; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PIPERIDINE DERIVATIVE; PROTEIN BCL 2; PURINE DERIVATIVE; ROSCOVITINE;

APOPTOSIS; ARTICLE; CELL AGING; CELL SURVIVAL; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REGULATION; HUMAN; HUMAN CELL; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN TARGETING; RHEUMATOID ARTHRITIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

APOPTOSIS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASE 9; CYCLIN-DEPENDENT KINASES; FLAVONOIDS; HUMANS; NEUTROPHILS; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-BCL-2; PURINES;

EID: 84856021037     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030128     Document Type: Article

References (30)

1. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, et al. (2010) In vivo labeling with H20-H-2 reveals a human neutrophil lifespan of 5.4 days. Blood 116: 625-627.
2. Brach MA, deVos S, Gruss HJ, Herrmann F, (1992) Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80: 2920-2924.
3. Raza K, Scheel-Toellner D, Lee CY, Pilling D, Curnow SJ, et al. (2006) Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis. Arthritis Res Ther 8: R120.
4. Leuenroth SJ, Grutkoski PS, Ayala A, Simms HH, (2000) The loss of Mcl1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol 68: 158-166.
5. Moulding DA, Quayle JA, Hart CA, Edwards SW, (1998) Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood 92: 2495-2502.
6. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, et al. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12: 1056-1064.
7. Klausen P, Bjerregaard MD, Borregaard N, Cowland JB, (2004) End-stage differentiation of neutrophil granulocytes in vivo is accompanied by up-regulation of p27kip1 and down-regulation of CDK2, CDK4 and CDK6. J Leukoc Biol 75: 569-578.
8. Leitch AE, Riley NA, Sheldrake TA, Festa M, Fox S, et al. (2010) The cyclin-dependent kinase inhibitor R-roscovitine down regulates Mcl-1 to overcome pro-inflammatory survival signalling and drive neutrophil apoptosis. Eur J Immunol 40: 1127-1138.
9. Arris CE, Boyle FT, Calvert AH, Curtin NJ, Endicott JA, et al. (2000) Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem 43: 2797-804.
10. Johnson N, Bentley J, Wang L-Z, Newell DR, Robson CN, et al. (2010) Pre-clinical evaluation of cyclin-dependent kinase 1 and 2 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. Br J Cancer 102: 342-350.
11. Sroka IM, Heiss EH, Havlicek L, Totzke F, Aristei Y, et al. (2010) A novel roscovitine derivative potently induces G1-phase arrest in platelet-derived growth factor -BB activated vascular smooth muscle cells. Mol Pharmacol. 77: 255-261.
12. Wang S, Fischer PM, (2008) Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends Pharmacol Sci. 29: 302-313.
13. Marshall NF, Peng J, Xie Z, Price DH, (1996) Control of RNA polymerase II elongation potential by a novel carboxy-terminal domain kinase. J Biol Chem 271: 27176-27183.
14. Gojo I, Zhang B, Fenston RG, (2002) The cyclin dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Clin Cancer Res 8: 3527-3538.
15. Rosato RR, Almenara JA, Kolla SS, Maggio SC, Coe S, et al. (2007) Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vironostat anti-leukaemic interactions. Mol Cancer Ther 6: 692-702.
16. Nasreen N, Mohammed KA, Sanders KL, Hardwick J, Van Horn RD, et al. (2003) Pleural mesothelial cells modulate polymorphonuclear leukocyte apoptosis in empyema. J Clin Immunol 23: 1-10.
17. Derouet M, Thomas L, Cross A, Moots RJ, Edwards SW, (2004) Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem 279: 26915-26921.
18. Scheel-Toellner D, Wang KQ, Henriquez NV, Webb PR, Craddock R, et al. (2002) Cytokine mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from PKB/AKT activation. Eur J Immunol 32: 486-493.
19. Wang K, Scheel-Toellner D, Wong SH, Craddock R, Caamano J, et al. (2003) Inhibition of neutrophil apoptosis by type 1 interferon depends on cross-talk between PI-3-kinase, protein kinase C-δ and NF-κB signaling pathways. J.Immunol. 171: 1035-1041.
20. Rosales JL, Ernst JD, Hallows J, Lee KY, (2004) GTP-dependent secretion from neutrophils is regulated by Cdk5. J Biol Chem. 279: 53932-53936.
21. Garriga J, Bhattacharya S, Calbo J, Marshall RM, Truongcao M, et al. (2003) CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol. 23: 5165-5173.
22. O'Keeffe B, Fong Y, Chen D, Zhou S, Zhou Q, (2000) Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem. 275: 279-287.
23. Aldridge AJ, (2002) Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surgery 168: 204-214.
24. Wright HL, Moots RJ, Bucknall RC, Edwards SW, (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology 9: 1618-1631.
25. Carvajal RD, Tse A, Shah MA, Lefkowitz RA, Gonen M, et al. (2009) A Phase II Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer. Pancreatology 9: 404-409.
26. Robak T, Jamroziak K, Robak P, (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69: 2415-2449.
27. Sekine C, Sugihara T, Miyake S, Hirai H, Yoshida M, et al. (2008) Successful treatment of animal models of rheumatoid arthritis with small molecule cyclin-dependent kinase inhibitors. J Immunol 180: 1954-1961.
28. Afford SC, Pongracz J, Stockley R, Crocker J, Burnett D, (1992) The induction by human interleukin-6 of apoptosis in the promyelocytic cell line U937 and human neutrophils. J Biol Chem 267: 21612-21616.
29. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, et al. (1989) Macrophage phagocytosis of aging neutrophils in inflammation- Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865-875.
30. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, et al. (2004) Reactive oxygen species limit neutrophil lifespan by activating death receptor signalling. Blood 104: 2557-2564.